Thiamine Diphosphate Status and Dialysis-Related Losses in End-Stage Kidney Disease Patients Treated with Hemodialysis.

Blood Purif 2017 28;44(4):294-300. Epub 2017 Oct 28.

Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland.

Aim: (1) To describe the whole blood content of thiamine diphosphate (TDP), a biologically active form of vitamin B1 in end-stage kidney disease patients treated with hemodialysis (HD); (2) to establish the impact of a single HD procedure on TDP blood concentrations; and (3) to describe potential explanatory variables influencing TDP dialysis related losses, including dialysis prescription, vitamin B1 dietary intake and supplementation.

Methods: Single-center, cross-sectional study in 50 clinically stable maintenance HD patients. The assessment of whole blood TDP with the High Performance Liquid Chromatography method, before and after a single, middle-week dialysis session and analysis of clinical and laboratory parameters potentially influencing TDP status Results: We report a significant difference in TDP levels before and after HD sessions - 42.5 (95% CI 38.7-46.2) μg/L and 23.6 (95% CI 18.9-28.2) μg/L, respectively (p = 0.000). The magnitude of intradialytic TDP changes is highly variable among individuals and is negatively associated only with the body weight of the patients (p < 0.013). Vitamin B1 dietary intake and supplementation do not influence whole blood TDP and dialysis-related loss of TDP.

Conclusions: TDP, a bioactive compound of vitamin B1, is substantially lost during the HD procedure, and the magnitude of its loss is associated with the patient's body weight but it is not influenced by vitamin B1 dietary intake and standard supplementation dose.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000480651DOI Listing
October 2017
6 Reads

Publication Analysis

Top Keywords

dietary intake
12
vitamin dietary
12
tdp
9
disease patients
8
kidney disease
8
patients treated
8
body weight
8
blood tdp
8
end-stage kidney
8
treated hemodialysis
8
influencing tdp
8
thiamine diphosphate
8
vitamin
5
liquid chromatography
4
dialysis-related loss
4
performance liquid
4
loss tdpconclusions
4
chromatography method
4
high performance
4
method single
4

Similar Publications

High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine.

Eur J Clin Pharmacol 2000 Jun;56(3):251-7

Institute of Nutrition, Department of Human Nutrition, Friedrich-Schiller-University, Jena, Germany.

Objective: The influence of either orally administered S-benzoylthiamine-O-monophosphate (benfotiamine) or thiamine nitrate on the thiamine status was tested in a randomised, two-group comparison study in 20 end-stage renal disease (ESRD) patients. Main outcome measures were the pharmacokinetics of thiamine diphosphate (TDP) in blood, the in vitro erythrocyte transketolase activity, its activation coefficient (alpha-ETK) and the TDP concentration in erythrocytes.

Methods: After ingestion of a single dose of either 100 mg thiamine nitrate (corresponding to 305 micromol thiamine) or 100 mg benfotiamine (corresponding to 214 micromol thiamine), the blood levels of thiamine phosphate esters were analysed by means of high-performance liquid chromatography for a 24-h period. Read More

View Article
June 2000

High thiamine diphosphate level as a protective factor for Alzheimer's disease.

Neurol Res 2018 May 2:1-8. Epub 2018 May 2.

a State Key Laboratory of Medical Neurobiology & Collaborative Innovation Center for Brain Science, Department of Neurology , Zhongshan Hospital, Institutes of Brain Science, Fudan University , Shanghai , China.

Objectives Thiamine diphosphate (TDP) is an indispensable coenzyme for three key enzymes in glucose metabolism. Reduced TDP levels in patients with Alzheimer's disease (AD) has been widely demonstrated and is a diagnostic biomarker for the disease. In this study, we further explored the correlation between altered TDP metabolism and AD along with other risk factors. Read More

View Article
May 2018

Thiamine deficiency in tachypnoeic Cambodian infants.

Paediatr Int Child Health 2015 ;35(4):312-8

Mayo Medical School.

Background: Beriberi is endemic in South-east Asia. Diagnosis is based on clinical findings, but correlation of clinical features with blood thiamine concentrations is uncertain.

Objectives: To investigate in tachypnoeic Cambodian infants the correlation between whole blood thiamine diphosphate (TDP) concentrations, clinical findings and blood TDP levels after therapy. Read More

View Article
October 2016

Thiamine deficiency in tachypnoeic Cambodian infants.

Paediatr Int Child Health 2014 Oct 27:2046905514Y0000000162. Epub 2014 Oct 27.

Background: Beriberi is endemic in South-east Asia. Diagnosis is based on clinical findings, but correlation of clinical features with blood thiamine concentrations is uncertain. Objectives: To investigate in tachypnoeic Cambodian infants the correlation between whole blood thiamine diphosphate (TDP) concentrations, clinical findings and blood TDP levels after therapy. Read More

View Article
October 2014